Precision targeting tumor cells using cancer-specific InDel mutations with CRISPR-Cas9
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Precision targeting tumor cells using cancer-specific InDel mutations with CRISPR-Cas9
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 119, Issue 9, Pages -
Publisher
Proceedings of the National Academy of Sciences
Online
2022-02-26
DOI
10.1073/pnas.2103532119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pan-cancer analysis of whole genomes
- (2020) NATURE
- The mutational constraint spectrum quantified from variation in 141,456 humans
- (2020) Konrad J. Karczewski et al. NATURE
- Transcription-coupled repair and mismatch repair contribute towards preserving genome integrity at mononucleotide repeat tracts
- (2020) Ilias Georgakopoulos-Soares et al. Nature Communications
- PDX models of human lung squamous cell carcinoma: consideration of factors in preclinical and co-clinical applications
- (2020) Hae-Yun Jung et al. Journal of Translational Medicine
- DNA double-strand break repair-pathway choice in somatic mammalian cells
- (2019) Ralph Scully et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites
- (2019) Rajeswari Jayavaradhan et al. Nature Communications
- qDSB-Seq is a general method for genome-wide quantification of DNA double-strand breaks using sequencing
- (2019) Yingjie Zhu et al. Nature Communications
- Comprehensive Characterization of Cancer Driver Genes and Mutations
- (2018) Matthew H. Bailey et al. CELL
- Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element
- (2018) Seung Woo Cho et al. CELL
- Strelka2: fast and accurate calling of germline and somatic variants
- (2018) Sangtae Kim et al. NATURE METHODS
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
- (2018) Christopher A. Vakulskas et al. NATURE MEDICINE
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR–Cas9 genome-editing efficiency
- (2017) Marella D Canny et al. NATURE BIOTECHNOLOGY
- Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene
- (2017) Zhang-Hui Chen et al. NATURE BIOTECHNOLOGY
- Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells
- (2017) Robin M Meyers et al. NATURE GENETICS
- Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression
- (2017) Taeyoung Koo et al. NUCLEIC ACIDS RESEARCH
- Inhibition of HIF1α and PDK Induces Cell Death of Glioblastoma Multiforme
- (2017) Jiwon Esther Han et al. Experimental Neurobiology
- DNA Breaks and End Resection Measured Genome-wide by End Sequencing
- (2016) Andres Canela et al. MOLECULAR CELL
- DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated Breaks
- (2016) Megan van Overbeek et al. MOLECULAR CELL
- High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
- (2016) Benjamin P. Kleinstiver et al. NATURE
- Consequences of Cas9 cleavage in the chromosome ofEscherichia coli
- (2016) Lun Cui et al. NUCLEIC ACIDS RESEARCH
- Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
- (2016) A. J. Aguirre et al. Cancer Discovery
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
- (2015) Traver Hart et al. CELL
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
- (2015) Takeshi Maruyama et al. NATURE BIOTECHNOLOGY
- Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases
- (2014) S. Bae et al. BIOINFORMATICS
- Trimmomatic: a flexible trimmer for Illumina sequence data
- (2014) Anthony M. Bolger et al. BIOINFORMATICS
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
- (2014) S. Kim et al. GENOME RESEARCH
- Quantitation of DNA double-strand break resection intermediates in human cells
- (2013) Yi Zhou et al. NUCLEIC ACIDS RESEARCH
- CRISPR Interference Can Prevent Natural Transformation and Virulence Acquisition during In Vivo Bacterial Infection
- (2012) David Bikard et al. Cell Host & Microbe
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Genomic instability — an evolving hallmark of cancer
- (2010) Simona Negrini et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Sequence- and Structure-Specific RNA Processing by a CRISPR Endonuclease
- (2010) Rachel E. Haurwitz et al. SCIENCE
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- Comparison of nonhomologous end joining and homologous recombination in human cells
- (2008) Z MAO et al. DNA REPAIR
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started